Cormedix Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cormedix Inc. on February 7, 2013, covering events occurring on February 1, 2013. The company is incorporated in Delaware and maintains its principal executive offices in Bridgewater, New Jersey.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance status regarding stock exchange listing standards.
Material Changes and Listing Status
On February 1, 2013, Cormedix Inc. received notice from the NYSE MKT LLC granting an extension until April 15, 2013, to regain compliance with continued listing standards. This follows a history of non-compliance notifications dating back to April 20, 2012, citing substantial sustained losses and impaired financial condition that raised questions about the company's ability to continue operations or meet obligations. The company previously submitted a compliance plan on May 17, 2012, which was accepted, leading to prior extensions through August 2012 and January 2013.
Outlook, Risks, and Contingencies
The company is subject to periodic review by the NYSE MKT during the extension period. The primary risk identified is potential delisting from the NYSE MKT if the company fails to make progress consistent with its compliance plan or fails to regain compliance by the April 15, 2013 deadline. No specific financial guidance or management commentary regarding future operational performance is included in this filing.
Investor Verification Checklist
- Verify the specific milestones and requirements outlined in the company's compliance plan accepted by the NYSE MKT.
- Monitor subsequent filings for updates on the company's financial condition and progress toward compliance before the April 15, 2013 deadline.
- Review the attached press release (Exhibit 99.1) for additional details on the extension and management's response.
- Assess the risk of delisting and its potential impact on stock liquidity and trading venue.